FindTrial
Sign In

Prognosis of Soft-Tissue Tumour

Study of Soft-Tissue Tumour by analysis of Prognostic factors Including Immunohistochemistry and Other Molecular Data - CH-STT

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200060241
Enrollment
Unknown
Registered
2022-05-23
Start date
2022-05-16
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Soft Tissue Tumour

Interventions

Observation:None

Sponsors

Shanghai Changhai Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
1 Years to 79 Years

Inclusion criteria

Inclusion criteria: 1.Age < 80 years; 2.Pathological result of soft tissue tumor.

Exclusion criteria

Exclusion criteria: 1. Without pathological specimen.

Design outcomes

Primary

MeasureTime frame
Complications;Recurrence Free Survival;Overall Survival;Adverse Surgical Outcome;—

Countries

China

Contacts

Public ContactRui Chen

Shanghai Changhai Hospital

drchenrui@foxmail.com+86 13764301103

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026